Abstract:Objective To investigate the effect of transurethral columnar balloon dilation of the prostate(TUCBDP)combined with transurethral resection of prostate(TURP)in the treatment of intravesical protrusion with over 1 cm of hyperplasia of prostate.Methods A total of 40 patients with intravesical protrusion with over 1 cm of prostatic hyperplasia admitted to the First Affiliated Hospital of Jiangxi Medical College from August 2018 to August 2020 were selected as the research subjects,they were divided into the experimental group and the control group according to the overall stratified grouping randomization method,with 20 cases in each group.The control group was treated with TURP,and the test group was treated with TUCBDP combined with TURP.After 6 months of continuous follow-up,the scores of the international prostate symptom scale(IPSS),the quality of life(QOL)assessment scale and the maximum urine flow rate(MFR)were recorded between the two groups.Results The IPSS scores of the two groups after operation were lower than those before operation,the QOL scores of the two groups after operation were higher than those before operation,and the IPSS score of the experimental group after operation was lower than that of the control group,and the QOL score of the experimental group after operation was higher than that of the control group,the differences were statistically significant(P<0.05).The MFR of the two groups at 1 month after operation were higher than those before operation,and the MFR of the experimental group at 1 month after operation was higher than that of the control group,the differences were statistically significant(P<0.05).Conclusion TUCBDP combined with TURP in the treatment of intravesical protrusion with over 1 cm of prostatic hyperplasia can effectively improve the symptom relief of patients,and improve their MFR and quality of life.
孔敏;陈俊;袁吴靓. TUCBDP联合TURP治疗突入膀胱大于1cm前列腺疗效分析[J]. 中国当代医药, 2021, 28(13): 106-108.
KONG Min;CHEN Jun;YUAN Wu-liang. Efficacy analysis of TUCBDP combined with TURP in the treatment of prostate with more than 1 cm protruding bladder. 中国当代医药, 2021, 28(13): 106-108.